SCHEMBL2015048

SCHEMBL2015048

CN(C(=O)c1cccc(-c2ccccn2)c1)C(CCNC(=O)c1cccn1C)Cc1ccccc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.72
HCRTR2 O43614 2/20 0.72
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
CTSL P07711 1/20 0.43
CTSB P07858 1/20 0.43
CTSS P25774 1/20 0.43
PADI4 Q9UM07 3/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
TP53 P04637 1/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2013804 0.94 HCRTR1 (0.73) HCRTR1HCRTR2NPC1RAB9ACTSL
SCHEMBL2010953 0.88 HCRTR1 (0.69) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL13139060 0.87 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL13139093 0.86 HCRTR1 (0.77) HCRTR1HCRTR2NPC1RAB9ACTSL
SCHEMBL2010792 0.86 HCRTR1 (0.67) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL2017387 0.85 HCRTR1 (0.71) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL6920111 0.85 HCRTR1 (0.68) HCRTR1HCRTR2NPC1RAB9ACTSL
SCHEMBL2015121 0.85 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9APADI4
SCHEMBL6919915 0.85 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9A
SCHEMBL2012115 0.85 HCRTR1 (0.65) HCRTR1HCRTR2NPC1RAB9APADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO claimed
WO-2011073316-A1 4-ARYL-BUTANE-1,3-DIAMIDES NOVARTIS AG (CH) 2011-06-23 WO disclosed